Targeted Hypoglossal Neurostimulation Study #3

NACompletedINTERVENTIONAL
Enrollment

138

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

June 30, 2019

Study Completion Date

September 1, 2023

Conditions
Obstructive Sleep Apnea
Interventions
DEVICE

aura6000 System

The aura6000 System is intended to unilaterally stimulate the hypoglossal nerve which innervates the muscles of the tongue. The aura6000 System stimulates the hypoglossal nerve cyclically and continuously during sleep to maintain muscle tone of the tongue and upper airway during sleep. Stimulation is generated by a programmable, multi-current source, implantable neurostimulator (IPG) and delivered to the hypoglossal nerve by a lead with multi-contact cuff electrode (lead).

Trial Locations (20)

1200

Clinique Univ. Saint-Luc, Brussels

10016

ENT and Allergy Associates, New York

21224

Johns Hopkins University, Baltimore

29425

Medical University of South Carolina, Charleston

30342

Advanced ENT Asociates, Atlanta

33487

Ear, Nose, and Throat Associates of South Florida, Boca Raton

34695

Morton Plant Mease Healthcare, Safety Harbor

38104

UT Methodist Physicians, Memphis

40218

Kentucky Research Group, Louisville

45245

Intrepid Research, Cincinnati

46032

Center for ENT and Allergy, Carmel

75013

Pitie Salpetriere, Paris

78731

FutureSearch Trials, Austin

90048

Tower ENT, Los Angeles

91911

ENT Associates of San Diego, Chula Vista

92108

SENTA Clinic, San Diego

Unknown

Foch Hospital, Suresnes

Ruprechts-Karls University, Mannheim

Bnai Zion Medical Center, Haifa

Hospital CUF Porto, Porto

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

LivaNova

INDUSTRY

lead

ImThera Medical, Inc.

INDUSTRY